What does the new patent box tax regime mean for your IP (and R&D) strategy?

Switzerland is preparing a major corporate tax law change to comply with the new OECD international tax practice recommendations (BEPS Action 5) [Update: Swiss Parliament voted the new law in June 2016 , but finally the law was not accepted by the Swiss citizens consulted by referendum in February 2017. A new tax reform in currently back in the legislative agenda, which will take a few more years. The content of this article is therefore obsolete.]

The former tax rulings regimes which were quite opaque and only accessible to multinationals will be abandoned in favour of a more transparent system, that will be more beneficial to local SMEs and corporations with active R&D in Switzerland, in particular through a couple of measures:

  1. A Swiss patent box, for optimising tax on benefits which can be bound to certain qualifying IP, such as patents and equivalent rights if substantial activities, i.e. local R&D expenditures, are effectively carried out by the taxpayer (here, Switzerland is aligning to the OECD rules, incl. the NEXUS ratio)
  2. R&D investment deduction incentives, for optimising R&D investments and thus encouraging innovation.

Continue reading

Genome editing applications – Brussels – Feb 3-4, 2016

IPStudies will be attending the next Genome Editing Applications event in Brussels, now postponed to 3 – 4 February 2016.

A number of companies identified in our CRISPR patent landscape will be speaking there, such as CRISPR Therapeutics (TJ Cradick), Cellectis (Philippe Duchateau), AstraZeneca (Lorenz Mayr), Janssen R&D (Ines Royaux), Novartis (Anett Ritter), Cellecta (Paul Diehl), Merck & Co (Myung Shin), Precision Biosciences (Victor Bartsevitch), as well as instutional applicants such as the Technical University of Denmark, the Netherlands Cancer Institute, Duke University, Wellcome Trust Sanger Institute, and Royal Holloway-University of London.

The event also features a dedicated, interactive evening seminar, discussion and dinner on Intellectual Property and Business Strategy Landscape of Genome Editing Technologies, to be lead by Dr. Philip Webber from Dehns (UK Patent and Trade Mark Attorneys). More information can be found here.

For those attending, we invite you to take this opportunity to meet our head of biotech IP analytics, Dr. Fabien Palazzoli – ask a demo of our interactive CRISPR patent landscape for genome editing R&D/IP positioning! Our free sample can be downloaded here.

 

IP management practices – Findings from the CRISPR-Cas landscape

When initially building our CRISPR-Cas patent landscape database over this summer, we were surprised by some unusual inventor patterns. As we now monitoring deeper into this data subset for our customers, we are further amazed by how some inventors and applicants are already strongly defending their IP position by various means in the diversity of international patent prosecution law practices – an IP management lesson of its own!

Continue reading

Colloque P2i 2013 – 2-3 octobre à Paris

Propriété Intellectuelle et Innovation

Le 2 et 3 octobre au coeur de Paris se tiendra la première édition du colloque P2i, Propriété Intellectuelle et Innovation, avec un programme très dense comprenant notamment plusieurs sessions dédiées à la gestion, à la stratégie et aux bonnes pratiques en matière de PI.

Une vingtaine de praticiens expérimentés, venant de différents secteurs allant de l’automobile aux télécoms en passant par l’aéronautique, partageront leurs expériences.

Corinne Le Buhan y présentera de “Nouvelles tactiques de déminage et camouflage au service d’une stratégie PI défensive“: observations de tiers auprès des 3 principaux offices, plateformes de crowdsourcing pour la recherche d’art antérieur, organisation et mise en oeuvre  pour maximiser les investissements tout au long du cycle de développement des produits technologiques à forte valeur ajoutée.

Les inscriptions sont encore possibles ici.

IEEPI training – Best practices of international licensing agreements

IEEPI (Institut Européen Entreprise et Propriété Industrielle) organizes in 2013 a new training on best practices of international licensing agreements in collaboration with Corinne Le Buhan from IPstudies SARL. 

Next session: 27.09.2013 09:00-17:30

Location: Paris, France

Language: English

Description: This practice course will focus on licensing strategies, preparation of the IP agreement proposal, the anatomy of a licensing agreement and negotiation of a licensing contract.

Target audience: Business development managers, licensing executives, IP practitioners, contract managers, technology transfer managers, lawyers.

Level of expertise: intermediate

Details and registration form: http://bit.ly/Y1dTy0

Niptech Innovation podcast interview

The French-speaking weekly technology podcast NipTech recently launched a new series dedicated to innovation best practices & experiences at the initiative of Benoît Curdy.

Corinne Le Buhan from IPStudies was invited last January to talk about her experience in IP management practice, in particular the early stage patent-or-not-patent challenge, as well as open innovation platforms experience and sources of innovation inspiration:

Links associated with the interview:

Thanks a lot again to Benoît for the nice interview and great editing work!

Conférence “La propriété intellectuelle pour les PME” à Fribourg

Le 24 janvier à 17h, à Fribourg, l’Association Romande de Propriété Intellectuelle (AROPI) et le Pôle Scientifique et Technologique du canton de Fribourg organisent une conférence sur l’importance stratégique de la PI pour les PME, avec des témoignages d’experts PI et un partage d’expérience de plusieurs PME concernant les brevets, modèles, marques et noms de domaine.

Inscription gratuite en ligne jusqu’au 20 janvier ici:

http://www.pst-fr.ch/conferences/pipme/inscription/

Balancing IP expenses and IP revenue – lessons from the CNRS challenge

Mid November, CNRS, the French largest public-funded research organization of more than 26000 employees, primarily researchers and engineers, announced a new technology transfer program for about 25% of their 4500 patent families portfolio. This is just yet another move in the patent monetization trend – and some of the financial figures at stake, more easily available for this public organization than for corporate world ones, deserve a closer scrutiny.

Continue reading

A new approach to predicting technology product lifecycle transitions

Beyond statistical research on patent databases for the purpose of identifying global economic trends, an even more interesting application of patent analysis is the search for indicators associated to a given sector. In particular, since patents are a priori a reflection of innovation, the corresponding indicators need to reflect the latter’s economic models, in particular the product lifecycle models (PLC model) commonly used in strategic marketing and strategic planning.

Continue reading